NM_001199107.2(TBC1D24):c.354C>G (p.Leu118=) AND multiple conditions

Germline classification:: Likely benign (1 submission)
Last evaluated:: Aug 9, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002188689.6

Allele description [Variation Report for NM_001199107.2(TBC1D24):c.354C>G (p.Leu118=)]

NM_001199107.2(TBC1D24):c.354C>G (p.Leu118=)

Gene:

TBC1D24:TBC1 domain family member 24 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p13.3

Genomic location:

Preferred name:

NM_001199107.2(TBC1D24):c.354C>G (p.Leu118=)

HGVS:

NC_000016.10:g.2496502C>G
NG_028170.1:g.26357C>G
NM_001199107.2:c.354C>GMANE SELECT
NM_020705.3:c.354C>G
NP_001186036.1:p.Leu118=
NP_065756.1:p.Leu118=
NC_000016.9:g.2546503C>G

Links:

dbSNP: rs2141871420

NCBI 1000 Genomes Browser:

rs2141871420

Molecular consequence:

NM_001199107.2:c.354C>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_020705.3:c.354C>G - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: Developmental and epileptic encephalopathy, 1 (DEE1)
Synonyms:: INFANTILE SPASM SYNDROME, X-LINKED 1; X-linked infantile spasms; West's syndrome; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0010632; MedGen: C3463992; OMIM: 308350

Name:: Autosomal dominant nonsyndromic hearing loss 65
Synonyms:: Deafness, autosomal dominant 65
Identifiers:: MONDO: MONDO:0014470; MedGen: C3892048; Orphanet: 90635; OMIM: 616044

Name:: Caused by mutation in the TBC1 domain family, member 24
Identifiers:: MedGen: CN236805

Recent activity

Clear Turn Off Turn On

Appendix B. Quality assessment methods for drug class reviews for the Drug Effec...
Appendix B. Quality assessment methods for drug class reviews for the Drug Effectiveness Review Project - Drug Class Review on HMG-CoA Reductase Inhibitors (Statins)
Appendix A. Search strategy - Drug Class Review on HMG-CoA Reductase Inhibitors ...
Appendix A. Search strategy - Drug Class Review on HMG-CoA Reductase Inhibitors (Statins)
1-deoxy-D-xylulose-5-phosphate synthase [Aquimarina sp. W85]
1-deoxy-D-xylulose-5-phosphate synthase [Aquimarina sp. W85]
gi|2811618958|gnl|PRJNA1162679|ACE9 815|gb|XHH97320.1|

Protein
1-deoxy-D-xylulose-5-phosphate synthase [Aquimarina sp. SS2-1]
1-deoxy-D-xylulose-5-phosphate synthase [Aquimarina sp. SS2-1]
gi|2811622364|gnl|PRJNA1162685|ACE9 965|gb|XHH93145.1|

Protein
Cycloteuthis sirventi voucher CEPH106-MML-AFSC-NOAA Fisheries large subunit ribo...
Cycloteuthis sirventi voucher CEPH106-MML-AFSC-NOAA Fisheries large subunit ribosomal RNA gene, partial sequence; mitochondrial
gi|2606449807|gb|OR742278.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002482854	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely benign (Aug 9, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002482854

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely benign
(Aug 9, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002482854.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine